中文名:DCL (PSMA抑制剂) ,ACUPA修饰氨基
英文名:DCL (PSMA inhibitor) (ACUPA)
CAS:N/A
一、Product parameters:
1.Molecular formula:C12H21N3O7
2.Molecular weight:319.31
3.Packaging specification:1g、5g、10g, flexible packaging, including 100mg packaging and 500mg 1g and 5g large packaging
Product structure:
二、Reaction characteristics:
DCL (PSMA inhibitor) (ACUPA)是一种通过氨基修饰的氨基酸,是一种新型的抑制剂,它针对列腺特异性膜抗原(PSMA)具有高度抑制作用。通过化学合成的方法将其引入多肽中,从而改变多肽的性质和活性。ACUPA修饰氨基具有稳定性和水溶性,可以增强多肽的亲和力和选择性,从而提高多肽的药效和生物活性。它还可以改变多肽的代谢和分布。
ACUPA修饰氨基可以在药物研发、生物学研究和治疗方面发挥重要作用。ACUPA修饰氨基是一种具有稳定性和水溶性的氨基酸,它可以增强多肽的亲和力和选择性,从而提高多肽的药效和生物活性。
在临床研究中,DCL已经显示出对PSMA阳性肿瘤细胞的高度抑制作用。通过静脉注射给予DCL,可以显著降低PSMA阳性肿瘤细胞的数量和大小,而对正常细胞没有明显的副作用。此外,DCL还可以与免疫治疗药物联合使用,以增强抗肿瘤效果。
三、Matters for use:
It is sensitive to light and temperature. In order to use the reagent effectively, the material should always be kept in a low temperature dry condition, away from light, and avoid frequent thawing and freezing.
四、storage conditions:
Store at - 20 ℃ as much as possible. If conditions permit, the material can be treated under inert gas to obtain better stability of the reagent.
【Reagent related products】
DOTA-(COOt-Bu)3-CH2-Alkynyl
DOTA-CH2-Alkynyl (TFA salt)
PSMA1007
DOTA-CH2-Alkynyl(HCl salt)
DOTA-Acrylamide
tert-Butyl-DCL (PSMA inhibitor)
PSMA-ICG
(S)-DOTAGA-(COOt-Bu)4
DOTA-PEG3-azide
PSMA617
PSMA11
DOTA-PEG5-amine
DOTA-PEG5-DBCO
NOTA-PSMA
DCL (PSMA inhibitor) (ACUPA)
PSMA-ligand-1
DOTA-PEG5-azide
DOTA-PEG4-MeTz
Stearic acid-PEG-Folate,STA-PEG-FA,MW:5000
Stearic acid-PEG-Folate,STA-PEG-FA,MW:3400
Stearic acid-PEG-Folate,STA-PEG-FA,MW:2000
Stearic acid-PEG-Folate,STA-PEG-FA,MW:1000
Fmoc-FAPI-4/ SCHEMBL21257089
FITC-PEG-FA,Fluorescein-PEG-Folic acid,MW:1000
FITC-PEG-FA,Fluorescein-PEG-Folic acid,MW:2000
FITC-PEG-FA,Fluorescein-PEG-Folic acid,MW:3400